Clinical Trials Browser

Breast Neoplasms, Carcinoma, Carcinoma, Intraductal, Noninfiltrating, Coronary Artery Disease, Coronary Disease, Heart Diseases, Lung Neoplasms, Lymphoma, Neoplasms, Cardiotoxicity

NCT02423356 2018-08-21

Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin

Completed

12 enrolled

BreastLymphoidSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Cardiotoxicity

NCT01904331 2018-06-15

BLOC

Completed

700 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT00875238 2018-02-19

PACE in BC

Completed

133 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT01022086 2017-07-12

Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab

Unknown

50 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Cardiotoxicity

NCT02065908 2016-12-08

Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer

Completed

128 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT00002900 2015-10-19

SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial

Completed

180 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Cardiotoxicity

NCT00968682 2014-12-31

CADY Study ICORG 08-01

Completed

480 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT02101879 2014-05-02

Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes

Unknown

20 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT00679874 2011-10-04

Cardiotox

Terminated

66 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT01246856 2011-09-12

TOXTAC

Unknown

150 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

Clinical Trials

C-BREAST-01

G-COR

ML-CardioTox

Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

SCARA-B

BRAVE-HEART

CCT2

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients

BLOC-II

Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

UCARE

AQUA

RADAF

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients

Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients

Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy

Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients

Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab

EARLY-CATCH

Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines

CAROLE

Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin

BLOC

PACE in BC

Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab

Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer

SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial

CADY Study ICORG 08-01

Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes

Cardiotox

TOXTAC